nach oben

Experimental Brain Research

Erschienen in:

01.06.2009 | Review

Mode of action of cytokines on nociceptive neurons

verfasst von: Nurcan Üçeyler, Maria Schäfers, Claudia Sommer

Erschienen in: Experimental Brain Research | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Cytokines are pluripotent soluble proteins secreted by immune and glial cells and are key elements in the induction and maintenance of pain. They are categorized as pro-inflammatory cytokines, which are mostly algesic, and anti-inflammatory cytokines, which have analgesic properties. Progress has been made in understanding the mechanisms underlying the action of cytokines in pain. To date, several direct and indirect pathways are known that link cytokines with nociception or hyperalgesia. Cytokines may act via specific cytokine receptors inducing downstream signal transduction cascades, which then modulate the function of other receptors like the ionotropic glutamate receptor, the transient vanilloid receptors, or sodium channels. This receptor activation, either through amplification of the inflammatory reaction, or through direct modulation of ion channel currents, then results in pain sensation. Following up on results from animal experiments, cytokine profiles have recently been investigated in human pain states. An imbalance of pro- and anti-inflammatory cytokine expression may be of importance for individual pain susceptibility. Individual cytokine profiles may be of diagnostic importance in chronic pain states, and, in the future, might guide the choice of treatment.

Alexander GM, van Rijn MA, van Hilten JJ, Perreault MJ, Schwartzman RJ (2005) Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain 116:213–219PubMedCrossRef

Alexander GM, Perreault MJ, Reichenberger ER, Schwartzman RJ (2007) Changes in immune and glial markers in the CSF of patients with complex regional pain syndrome. Brain Behav Immun 21:668–676PubMedCrossRef

Allen BJ, Rogers SD, Ghilardi JR, Menning PM, Kuskowski MA, Basbaum AI, Simone DA, Mantyh PW (1997) Noxious cutaneous thermal stimuli induce a graded release of endogenous substance P in the spinal cord: imaging peptide action in vivo. J Neurosci 17:5921–5927PubMed

Amel Kashipaz MR, Swinden D, Todd I, Powell RJ (2003) Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells. Clin Exp Immunol 132:360–365PubMedCrossRef

Baldwin AS Jr (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14:649–683PubMedCrossRef

Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, Beattie MS, Malenka RC (2002) Control of synaptic strength by glial TNF alpha. Science 295:2282–2285PubMedCrossRef

Bernateck M, Rolke R, Birklein F, Treede RD, Fink M, Karst M (2007) Successful intravenous regional block with low-dose tumor necrosis factor-alpha antibody infliximab for treatment of complex regional pain syndrome 1. Anesth Analg 105:1148–1151 table of contentsPubMedCrossRef

Birklein F, Schmelz M, Schifter S, Weber M (2001) The important role of neuropeptides in complex regional pain syndrome. Neurology 57:2179–2184PubMed

Börner C, Woltje M, Hollt V, Kraus J (2004) STAT6 transcription factor binding sites with mismatches within the canonical 5′-TTC…GAA-3′ motif involved in regulation of delta- and mu-opioid receptors. J Neurochem 91:1493–1500PubMedCrossRef

Calixto JB, Cabrini DA, Ferreira J, Campos MM (2000) Kinins in pain and inflammation. Pain 87:1–5PubMedCrossRef

Cao YQ, Mantyh PW, Carlson EJ, Gillespie AM, Epstein CJ, Basbaum AI (1998) Primary afferent tachykinins are required to experience moderate to intense pain. Nature 392:390–394PubMedCrossRef

Chen NN, Wu SG (1999) Effect of recombinant human interleukin-1 beta on K+ channels of mice bone marrow stromal cells. Sheng Li Xue Bao 51:637–644PubMed

Ching DW, McClintock A, Beswick F (2003) Successful treatment with low-dose thalidomide in a patient with both Behcet’s disease and complex regional pain syndrome type I: case report. J Clin Rheumatol 9:96–98PubMedCrossRef

Choi JY, Choi YS, Kim SJ, Son EJ, Choi HS, Yoon JH (2007) Interleukin-1beta suppresses epithelial sodium channel beta-subunit expression and ENaC-dependent fluid absorption in human middle ear epithelial cells. Eur J Pharmacol 567:19–25PubMedCrossRef

Coudore-Civiale MA, Courteix C, Eschalier A, Fialip J (1998) Effect of tachykinin receptor antagonists in experimental neuropathic pain. Eur J Pharmacol 361:175–184PubMedCrossRef

Cuellar JM, Montesano PX, Carstens E (2004) Role of TNF-alpha in sensitization of nociceptive dorsal horn neurons induced by application of nucleus pulposus to L5 dorsal root ganglion in rats. Pain 110:578–587PubMedCrossRef

Cunha FQ, Lorenzetti BB, Poole S, Ferreira SH (1991) Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol 104:765–767PubMed

Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH (1992) The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 107:660–664PubMed

Cunha FQ, Poole S, Lorenzetti BB, Veiga FH, Ferreira SH (1999) Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4. Br J Pharmacol 126:45–50PubMedCrossRef

Cunha TM, Verri WA Jr, Silva JS, Poole S, Cunha FQ, Ferreira SH (2005) A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci USA 102:1755–1760PubMedCrossRef

Cunha TM, Verri WA Jr, Fukada SY, Guerrero AT, Santodomingo-Garzon T, Poole S, Parada CA, Ferreira SH, Cunha FQ (2007) TNF-alpha and IL-1beta mediate inflammatory hypernociception in mice triggered by B1 but not B2 kinin receptor. Eur J Pharmacol 573:221–229PubMedCrossRef

Cunningham AJ, Murray CA, O’Neill LA, Lynch MA, O’Connor JJ (1996) Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203:17–20PubMedCrossRef

Czeschik JC, Hagenacker T, Schäfers M, Büsselberg D (2008) TNF-alpha differentially modulates ion channels of nociceptive neurons. Neurosci Lett 434:293–298PubMedCrossRef

Czlonkowski A, Stein C, Herz A (1993) Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines. Eur J Pharmacol 242:229–235PubMedCrossRef

D’Arcangelo G, Dodt HU, Zieglgansberger W (1997) Reduction of excitation by interleukin-1 beta in rat neocortical slices visualized using infrared-darkfield videomicroscopy. Neuroreport 8:2079–2083PubMed

Dayer JM, Beutler B, Cerami A (1985) Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 162:2163–2168PubMedCrossRef

De A, Krueger JM, Simasko SM (2003) Tumor necrosis factor alpha increases cytosolic calcium responses to AMPA and KCl in primary cultures of rat hippocampal neurons. Brain Res 981:133–142PubMedCrossRef

Desson SE, Ferguson AV (2003) Interleukin 1beta modulates rat subfornical organ neurons as a result of activation of a non-selective cationic conductance. J Physiol 550:113–122PubMedCrossRef

Di Marzo V, Blumberg PM, Szallasi A (2002) Endovanilloid signaling in pain. Curr Opin Neurobiol 12:372–379PubMedCrossRef

Diem R, Meyer R, Weishaupt JH, Bahr M (2001) Reduction of potassium currents and phosphatidylinositol 3-kinase-dependent AKT phosphorylation by tumor necrosis factor-(alpha) rescues axotomized retinal ganglion cells from retrograde cell death in vivo. J Neurosci 21:2058–2066PubMed

Diem R, Hobom M, Grotsch P, Kramer B, Bahr M (2003) Interleukin-1 beta protects neurons via the interleukin-1 (IL-1) receptor-mediated Akt pathway and by IL-1 receptor-independent decrease of transmembrane currents in vivo. Mol Cell Neurosci 22:487–500PubMedCrossRef

Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA Jr, O’Connor JV (1986) Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 163:1433–1450PubMedCrossRef

Ding M, Hart RP, Jonakait GM (1995) Tumor necrosis factor-alpha induces substance P in sympathetic ganglia through sequential induction of interleukin-1 and leukemia inhibitory factor. J Neurobiol 28:445–454PubMedCrossRef

Donnerer J, Schuligoi R, Stein C (1992) Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 49:693–698PubMedCrossRef

Dray A (1997) Kinins and their receptors in hyperalgesia. Can J Physiol Pharmacol 75:704–712PubMedCrossRef

Dray A, Perkins M (1993) Bradykinin and inflammatory pain. Trends Neurosci 16:99–104PubMedCrossRef

Durham PL (2006) Calcitonin gene-related peptide (CGRP) and migraine. Headache 46(Suppl 1):S3–S8PubMedCrossRef

Empl M, Renaud S, Erne B, Fuhr P, Straube A, Schaeren-Wiemers N, Steck AJ (2001) TNF-alpha expression in painful and nonpainful neuropathies. Neurology 56:1371–1377PubMed

Ferreira SH, Lorenzetti BB, Bristow AF, Poole S (1988) Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334:698–700PubMedCrossRef

Fu LW, Longhurst JC (1999) Interleukin-1beta sensitizes abdominal visceral afferents of cats to ischaemia and histamine. J Physiol 521(Pt 1):249–260PubMedCrossRef

Fukuoka H, Kawatani M, Hisamitsu T, Takeshige C (1994) Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 beta in the rat. Brain Res 657:133–140PubMedCrossRef

Furukawa K, Mattson MP (1998) The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons. J Neurochem 70:1876–1886PubMedCrossRef

George A, Marziniak M, Schäfers M, Toyka KV, Sommer C (2000) Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin. Pain 88:267–275PubMedCrossRef

George A, Buehl A, Sommer C (2005) Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve. Exp Neurol 192:163–166PubMedCrossRef

Gür A, Karakoç M, Erdoğan S, Nas K, Çevik R, Sarac AJ (2002) Regional cerebral blood flow and cytokines in young females with fibromyalgia. Clin Exp Rheumatol 20:753–760PubMed

Hao S, Mata M, Glorioso JC, Fink DJ (2006) HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Mol Pain 2:6PubMedCrossRef

Hassan AH, Ableitner A, Stein C, Herz A (1993) Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 55:185–195PubMedCrossRef

Hoehe MR, Kopke K, Wendel B, Rohde K, Flachmeier C, Kidd KK, Berrettini WH, Church GM (2000) Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. Hum Mol Genet 9:2895–2908PubMedCrossRef

Hoheisel U, Unger T, Mense S (2005) Excitatory and modulatory effects of inflammatory cytokines and neurotrophins on mechanosensitive group IV muscle afferents in the rat. Pain 114:168–176PubMedCrossRef

Homma Y, Brull SJ, Zhang JM (2002) A comparison of chronic pain behavior following local application of tumor necrosis factor alpha to the normal and mechanically compressed lumbar ganglia in the rat. Pain 95:239–246PubMedCrossRef

Hou L, Li W, Wang X (2003) Mechanism of interleukin-1 beta-induced calcitonin gene-related peptide production from dorsal root ganglion neurons of neonatal rats. J Neurosci Res 73:188–197PubMedCrossRef

Houzen H, Kikuchi S, Kanno M, Shinpo K, Tashiro K (1997) Tumor necrosis factor enhancement of transient outward potassium currents in cultured rat cortical neurons. J Neurosci Res 50:990–999PubMedCrossRef

Huygen FJ, De Bruijn AG, De Bruin MT, Groeneweg JG, Klein J, Zijistra FJ (2002) Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm 11:47–51PubMedCrossRef

Huygen FJ, Niehof S, Zijlstra FJ, van Hagen PM, van Daele PL (2004) Successful treatment of CRPS 1 with anti-TNF. J Pain Symptom Manage 27:101–103PubMedCrossRef

Igarashi T, Kikuchi S, Shubayev V, Myers RR (2000) 2000 Volvo Award winner in basic science studies: exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine 25:2975–2980PubMedCrossRef

Inoue A, Ikoma K, Morioka N, Kumagai K, Hashimoto T, Hide I, Nakata Y (1999) Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system. J Neurochem 73:2206–2213PubMed

Jander S, Pohl J, Gillen C, Stoll G (1996) Differential expression of interleukin-10 mRNA in Wallerian degeneration and immune-mediated inflammation of the rat peripheral nervous system. J Neurosci Res 43:254–259PubMedCrossRef

Jin X, Gereau RWT (2006) Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J Neurosci 26:246–255PubMedCrossRef

Junger H, Sorkin LS (2000) Nociceptive and inflammatory effects of subcutaneous TNFalpha. Pain 85:145–151PubMedCrossRef

Kagan BL, Baldwin RL, Munoz D, Wisnieski BJ (1992) Formation of ion-permeable channels by tumor necrosis factor-alpha. Science 255:1427–1430PubMedCrossRef

Katsuki H, Nakai S, Hirai Y, Akaji K, Kiso Y, Satoh M (1990) Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol 181:323–326PubMedCrossRef

Kawasaki Y, Zhang L, Cheng JK, Ji RR (2008) Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 28:5189–5194PubMedCrossRef

Kessler W, Kirchhoff C, Reeh PW, Handwerker HO (1992) Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P. Exp Brain Res 91:467–476PubMedCrossRef

Kleinschnitz C, Brinkhoff J, Zelenka M, Sommer C, Stoll G (2004) The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling. J Neuroimmunol 149:77–83PubMedCrossRef

Koller H, Allert N, Oel D, Stoll G, Siebler M (1998) TNF alpha induces a protein kinase C-dependent reduction in astroglial K+ conductance. Neuroreport 9:1375–1378PubMed

Korn T, Magnus T, Jung S (2005) Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: a mechanism mediated by tumor necrosis factor-alpha. FASEB J 19:1878–1880PubMed

Kraus J, Börner C, Giannini E, Hickfang K, Braun H, Mayer P, Hoehe MR, Ambrosch A, Konig W, Hollt V (2001) Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem 276:43901–43908PubMedCrossRef

Lindenlaub T, Sommer C (2003) Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol 105:593–602PubMed

Liu B, Li H, Brull SJ, Zhang JM (2002) Increased sensitivity of sensory neurons to tumor necrosis factor alpha in rats with chronic compression of the lumbar ganglia. J Neurophysiol 88:1393–1399PubMedCrossRef

Liu L, Yang TM, Liedtke W, Simon SA (2006) Chronic IL-1beta signaling potentiates voltage-dependent sodium currents in trigeminal nociceptive neurons. J Neurophysiol 95:1478–1490PubMedCrossRef

Liu D, Jiang LS, Dai LY (2007) Substance P and its receptors in bone metabolism. Neuropeptides 41:271–283PubMedCrossRef

Ma C, Greenquist KW, Lamotte RH (2006) Inflammatory mediators enhance the excitability of chronically compressed dorsal root ganglion neurons. J Neurophysiol 95:2098–2107PubMedCrossRef

MacEwan DJ (2002) TNF receptor subtype signalling: differences and cellular consequences. Cell Signal 14:477–492PubMedCrossRef

Maes M, Libbrecht I, Van Hunsel F, Lin AH, De Clerck L, Stevens W, Kenis G, de Jongh R, Bosmans E, Neels H (1999) The immune-inflammatory pathophysiology of fibromyalgia: increased serum soluble gp130, the common signal transducer protein of various neurotrophic cytokines. Psychoneuroendocrinology 24:371–383PubMedCrossRef

Maingret F, Coste B, Padilla F, Clerc N, Crest M, Korogod SM, Delmas P (2008) Inflammatory mediators increase Nav1.9 current and excitability in nociceptors through a coincident detection mechanism. J Gen Physiol 131:211–225PubMedCrossRef

Malcangio M, Bowery NG, Flower RJ, Perretti M (1996) Effect of interleukin-1 beta on the release of substance P from rat isolated spinal cord. Eur J Pharmacol 299:113–118PubMedCrossRef

Manni L, Aloe L (1998) Role of IL-1 beta and TNF-alpha in the regulation of NGF in experimentally induced arthritis in mice. Rheumatol Int 18:97–102PubMedCrossRef

Manning DC (2006) Immunomodulatory agents for neuropathic pain syndromes: from animals to CRPS and beyond. Eur J Pain Suppl1: S20

Marceau F (1995) Kinin B1 receptors: a review. Immunopharmacology 30:1–26PubMedCrossRef

McLarnon JG, Franciosi S, Wang X, Bae JH, Choi HB, Kim SU (2001) Acute actions of tumor necrosis factor-alpha on intracellular Ca(2+) and K(+) currents in human microglia. Neuroscience 104:1175–1184PubMedCrossRef

Milligan ED, Langer SJ, Sloane EM, He L, Wieseler-Frank J, O’Connor K, Martin D, Forsayeth JR, Maier SF, Johnson K, Chavez RA, Leinwand LA, Watkins LR (2005a) Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci 21:2136–2148PubMedCrossRef

Milligan ED, Sloane EM, Langer SJ, Cruz PE, Chacur M, Spataro L, Wieseler-Frank J, Hammack SE, Maier SF, Flotte TR, Forsayeth JR, Leinwand LA, Chavez R, Watkins LR (2005b) Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Mol Pain 1:9PubMedCrossRef

Milligan ED, Sloane EM, Langer SJ, Hughes TS, Jekich BM, Frank MG, Mahoney JH, Levkoff LH, Maier SF, Cruz PE, Flotte TR, Johnson KW, Mahoney MM, Chavez RA, Leinwand LA, Watkins LR (2006) Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain 126:294–308PubMedCrossRef

Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A (2005) The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 99:6–38PubMedCrossRef

Morita K, Miyasako T, Kitayama S, Dohi T (2004) Interleukin-1 inhibits voltage-dependent P/Q-type Ca²⁺ channel associated with the inhibition of the rise of intracellular free Ca²⁺ concentration and catecholamine release in adrenal chromaffin cells. Biochim Biophys Acta 1673:160–169PubMed

Mousa SA, Zhang Q, Sitte N, Ji R, Stein C (2001) beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 115:71–78PubMedCrossRef

Murata Y, Onda A, Rydevik B, Takahashi I, Takahashi K, Olmarker K (2006) Changes in pain behavior and histologic changes caused by application of tumor necrosis factor-alpha to the dorsal root ganglion in rats. Spine 31:530–535PubMedCrossRef

Murphy PG, Ramer MS, Borthwick L, Gauldie J, Richardson PM, Bisby MA (1999) Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice. Eur J Neurosci 11:2243–2253PubMedCrossRef

Murray CA, McGahon B, McBennett S, Lynch MA (1997) Interleukin-1 beta inhibits glutamate release in hippocampus of young, but not aged, rats. Neurobiol Aging 18:343–348PubMedCrossRef

Nicol GD, Lopshire JC, Pafford CM (1997) Tumor necrosis factor enhances the capsaicin sensitivity of rat sensory neurons. J Neurosci 17:975–982PubMed

Niederberger E, Schmidtko A, Coste O, Marian C, Ehnert C, Geisslinger G (2006) The glutamate transporter GLAST is involved in spinal nociceptive processing. Biochem Biophys Res Commun 346:393–399PubMedCrossRef

Obreja O, Rathee PK, Lips KS, Distler C, Kress M (2002) IL-1 beta potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C. Faseb J 16:1497–1503PubMedCrossRef

Ogoshi F, Yin HZ, Kuppumbatti Y, Song B, Amindari S, Weiss JH (2005) Tumor necrosis-factor-alpha (TNF-alpha) induces rapid insertion of Ca²⁺-permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal neurons. Exp Neurol 193:384–393PubMedCrossRef

Okamoto K, Martin DP, Schmelzer JD, Mitsui Y, Low PA (2001) Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol 169:386–391PubMedCrossRef

Onda A, Hamba M, Yabuki S, Kikuchi S (2002) Exogenous tumor necrosis factor-alpha induces abnormal discharges in rat dorsal horn neurons. Spine 27:1618–1624 discussion 1624PubMedCrossRef

Onda A, Yabuki S, Kikuchi S (2003) Effects of neutralizing antibodies to tumor necrosis factor-alpha on nucleus pulposus-induced abnormal nociresponses in rat dorsal horn neurons. Spine 28:967–972PubMedCrossRef

Opree A, Kress M (2000) Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci 20:6289–6293PubMed

Özaktay AC, Cavanaugh JM, Asιk I, DeLeo JA, Weinstein JN (2002) Dorsal root sensitivity to interleukin-1 beta, interleukin-6 and tumor necrosis factor in rats. Eur Spine J 11:467–475PubMedCrossRef

Özaktay AC, Kallakuri S, Takebayashi T, Cavanaugh JM, Asιk I, DeLeo JA, Weinstein JN (2006) Effects of interleukin-1 beta, interleukin-6, and tumor necrosis factor on sensitivity of dorsal root ganglion and peripheral receptive fields in rats. Eur Spine J 15:1529–1537PubMedCrossRef

Perkins MN, Kelly D (1994) Interleukin-1 beta induced-desArg9bradykinin-mediated thermal hyperalgesia in the rat. Neuropharmacology 33:657–660PubMedCrossRef

Pesquero JB, Araujo RC, Heppenstall PA, Stucky CL, Silva JA Jr, Walther T, Oliveira SM, Pesquero JL, Paiva AC, Calixto JB, Lewin GR, Bader M (2000) Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci USA 97:8140–8145PubMedCrossRef

Piper AS, Yeats JC, Bevan S, Docherty RJ (1999) A study of the voltage dependence of capsaicin-activated membrane currents in rat sensory neurones before and after acute desensitization. J Physiol 518(Pt 3):721–733PubMedCrossRef

Plata-Salaman CR, Ffrench-Mullen JM (1992) Interleukin-1 beta depresses calcium currents in CA1 hippocampal neurons at pathophysiological concentrations. Brain Res Bull 29:221–223PubMedCrossRef

Plata-Salaman CR, ffrench-Mullen JM (1994) Interleukin-1 beta inhibits Ca²⁺ channel currents in hippocampal neurons through protein kinase C. Eur J Pharmacol 266:1–10PubMedCrossRef

Pollock J, McFarlane SM, Connell MC, Zehavi U, Vandenabeele P, MacEwan DJ, Scott RH (2002) TNF-alpha receptors simultaneously activate Ca²⁺ mobilisation and stress kinases in cultured sensory neurones. Neuropharmacology 42:93–106PubMedCrossRef

Poole S, Cunha FQ, Selkirk S, Lorenzetti BB, Ferreira SH (1995) Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br J Pharmacol 115:684–688PubMed

Rada P, Mark GP, Vitek MP, Mangano RM, Blume AJ, Beer B, Hoebel BG (1991) Interleukin-1 beta decreases acetylcholine measured by microdialysis in the hippocampus of freely moving rats. Brain Res 550:287–290PubMedCrossRef

Regoli D, Jukic D, Gobeil F, Rhaleb NE (1993) Receptors for bradykinin and related kinins: a critical analysis. Can J Physiol Pharmacol 71:556–567PubMed

Roux J, Kawakatsu H, Gartland B, Pespeni M, Sheppard D, Matthay MA, Canessa CM, Pittet JF (2005) Interleukin-1beta decreases expression of the epithelial sodium channel alpha-subunit in alveolar epithelial cells via a p38 MAPK-dependent signaling pathway. J Biol Chem 280:18579–18589PubMedCrossRef

Salemi S, Rethage J, Wollina U, Michel BA, Gay RE, Gay S, Sprott H (2003) Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. J Rheumatol 30:146–150PubMed

Sawada M, Hara N, Maeno T (1991) Tumor necrosis factor reduces the ACh-induced outward current in identified Aplysia neurons. Neurosci Lett 131:217–220PubMedCrossRef

Schäfer M, Carter L, Stein C (1994) Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 91:4219–4223PubMedCrossRef

Schäfers M, Geis C, Brors D, Yaksh TL, Sommer C (2002) Anterograde transport of tumor necrosis factor-alpha in the intact and injured rat sciatic nerve. J Neurosci 22:536–545PubMed

Schäfers M, Lee DH, Brors D, Yaksh TL, Sorkin LS (2003a) Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-alpha after spinal nerve ligation. J Neurosci 23:3028–3038PubMed

Schäfers M, Sorkin LS, Sommer C (2003b) Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain 104:579–588PubMedCrossRef

Schäfers M, Sommer C, Geis C, Hagenacker T, Vandenabeele P, Sorkin LX (2008) Selective stimulation of either tumor necrosis factor receptor differentially induces pain behavior in vivo and ectopic activity in sensory neurons in vitro. Neuroscience 157:414–423PubMedCrossRef

Schneider H, Pitossi F, Balschun D, Wagner A, del Rey A, Besedovsky HO (1998) A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci USA 95:7778–7783PubMedCrossRef

Scholz J, Woolf CJ (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10:1361–1368PubMedCrossRef

Schreur KD, Liu S (1997) Involvement of ceramide in inhibitory effect of IL-1 beta on L-type Ca²⁺ current in adult rat ventricular myocytes. Am J Physiol 272:H2591–H2598PubMed

Shu HF, Wang BR, Wang SR, Yao W, Huang HP, Zhou Z, Wang X, Fan J, Wang T, Ju G (2007) IL-1beta inhibits IK and increases [Ca²⁺]i in the carotid body glomus cells and increases carotid sinus nerve firings in the rat. Eur J Neurosci 25:3638–3647PubMedCrossRef

Sitcheran R, Gupta P, Fisher PB, Baldwin AS (2005) Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNF alpha-controlled repression. Embo J 24:510–520PubMedCrossRef

Sommer C, Petrausch S, Lindenlaub T, Toyka KV (1999) Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neurosci Lett 270:25–28PubMedCrossRef

Sommer C, Schäfers M, Marziniak M, Toyka KV (2001) Etanercept reduces hyperalgesia in experimental painful neuropathy. J Peripher Nerv Syst 6:67–72PubMedCrossRef

Sorkin LS, Xiao WH, Wagner R, Myers RR (1997) Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 81:255–262PubMedCrossRef

Steinman L (2007) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13:139–145PubMedCrossRef

Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-alpha. Nature 440:1054–1059PubMedCrossRef

Stellwagen D, Beattie EC, Seo JY, Malenka RC (2005) Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 25:3219–3228PubMedCrossRef

Stucky CL, Abrahams LG, Seybold VS (1998) Bradykinin increases the proportion of neonatal rat dorsal root ganglion neurons that respond to capsaicin and protons. Neuroscience 84:1257–1265PubMedCrossRef

Takahashi N, Kikuchi S, Shubayev VI, Campana WM, Myers RR (2006) TNF-alpha and phosphorylation of ERK in DRG and spinal cord: insights into mechanisms of sciatica. Spine 31:523–529PubMedCrossRef

Taskinen HS, Olsson T, Bucht A, Khademi M, Svelander L, Roytta M (2000) Peripheral nerve injury induces endoneurial expression of IFN-gamma, IL-10 and TNF-alpha mRNA. J Neuroimmunol 102:17–25PubMedCrossRef

Thacker MA, Clark AK, Marchand F, McMahon SB (2007) Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg 105:838–847PubMedCrossRef

Tiffany CW, Burch RM (1989) Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FEBS Lett 247:189–192PubMedCrossRef

Üçeyler N, Sommer C (2007) Cytokine-induced pain: basic science and clinical implications. Rev Analg 9:87–103CrossRef

Üçeyler N, Valenza R, Stock M, Schedel R, Sprotte G, Sommer C (2006) Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum 54:2656–2664PubMedCrossRef

Üçeyler N, Eberle T, Rolke R, Birklein F, Sommer C (2007a) Differential expression patterns of cytokines in complex regional pain syndrome. Pain 132:195–205PubMedCrossRef

Üçeyler N, Rogausch JP, Toyka KV, Sommer C (2007b) Differential expression of cytokines in painful and painless neuropathies. Neurology 69:42–49PubMedCrossRef

Üçeyler N, Kafke W, Toyka KV, Sommer C (2007c) Local and systemic cytokine expression in patients with small fiber neuropathy. JPNS 12:87

Üçeyler N, Tscharke A, Sommer C (2007d) Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain. Brain Behav Immun 21:553–560PubMedCrossRef

Vale ML, Marques JB, Moreira CA, Rocha FA, Ferreira SH, Poole S, Cunha FQ, Ribeiro RA (2003) Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats. J Pharmacol Exp Ther 304:102–108PubMedCrossRef

van der Goot FG, Pugin J, Hribar M, Fransen L, Dunant Y, De Baetselier P, Bloc A, Lucas R (1999) Membrane interaction of TNF is not sufficient to trigger increase in membrane conductance in mammalian cells. FEBS Lett 460:107–111PubMedCrossRef

Verri WA Jr, Cunha TM, Parada CA, Poole S, Cunha FQ, Ferreira SH (2006) Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? Pharmacol Ther 112:116–138PubMedCrossRef

Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M (2003) Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23:8692–8700PubMed

Wagner R, Janjigian M, Myers RR (1998) Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression. Pain 74:35–42PubMedCrossRef

Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH (2001) Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology (Oxford) 40:743–749CrossRef

Wang H, Kohno T, Amaya F, Brenner GJ, Ito N, Allchorne A, Ji RR, Woolf CJ (2005) Bradykinin produces pain hypersensitivity by potentiating spinal cord glutamatergic synaptic transmission. J Neurosci 25:7986–7992PubMedCrossRef

Wang H, Moser M, Schiltenwolf M, Buchner M (2008) Circulating cytokine levels compared to pain in patients with fibromyalgia—a prospective longitudinal study over 6 months. J Rheumatol 35:1366–1370PubMed

Weinreich D, Wonderlin WF (1987) Inhibition of calcium-dependent spike after-hyperpolarization increases excitability of rabbit visceral sensory neurones. J Physiol 394:415–427PubMed

Weng HR, Aravindan N, Cata JP, Chen JH, Shaw AD, Dougherty PM (2005) Spinal glial glutamate transporters downregulate in rats with taxol-induced hyperalgesia. Neurosci Lett 386:18–22PubMedCrossRef

Wesseldijk F, Huygen FJ, Heijmans-Antonissen C, Niehof SP, Zijlstra FJ (2008) Six years follow-up of the levels of TNF-alpha and IL-6 in patients with complex regional pain syndrome type 1. Mediators Inflamm 2008:469439PubMedCrossRef

Wolf G, Gabay E, Tal M, Yirmiya R, Shavit Y (2006) Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury in mice. Pain 120:315–324PubMedCrossRef

Yang S, Liu ZW, Wen L, Qiao HF, Zhou WX, Zhang YX (2005) Interleukin-1beta enhances NMDA receptor-mediated current but inhibits excitatory synaptic transmission. Brain Res 1034:172–179PubMedCrossRef

Zelenka M, Schäfers M, Sommer C (2005) Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain 116:257–263PubMedCrossRef

Zhang JM, Li H, Liu B, Brull SJ (2002) Acute topical application of tumor necrosis factor alpha evokes protein kinase A-dependent responses in rat sensory neurons. J Neurophysiol 88:1387–1392PubMedCrossRef

Zhou C, Ye HH, Wang SQ, Chai Z (2006) Interleukin-1beta regulation of N-type Ca²⁺ channels in cortical neurons. Neurosci Lett 403:181–185PubMedCrossRef

Titel: Mode of action of cytokines on nociceptive neurons
verfasst von: Nurcan Üçeyler
Maria Schäfers
Claudia Sommer
Publikationsdatum: 01.06.2009
Verlag: Springer-Verlag
Erschienen in: Experimental Brain Research / Ausgabe 1/2009
Print ISSN: 0014-4819
Elektronische ISSN: 1432-1106
DOI: https://doi.org/10.1007/s00221-009-1755-z

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Mode of action of cytokines on nociceptive neurons

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2009

Mechano- and thermosensitivity of regenerating cutaneous afferent nerve fibers

Translational nociceptor research as guide to human pain perceptions and pathophysiology

In search of lost presynaptic inhibition

Migraine: where and how does the pain originate?

Translating nociceptive processing into human pain models

Editorial

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie